Finance

Lists
Why is CHE up 2.66%?
Dive Deeper
CHE:NYSE
Chemed Corp
$548.64
+2.66%
(+14.22) 1D
$548.64
0.00% (0.00)
After hours
Closed: Nov 4, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHE...
Open
$545.00
High
$550.31
Low
$530.38
Mkt. cap
7.14B
Avg. vol.
154.09K
Volume
227.19K
Dividend
0.51%
Quarterly dividend
$0.70
Ex-dividend date
Aug 17, 2026
P/E ratio
26.23
52-wk high
$562.24
52-wk low
$365.20
EPS
$20.91
Beta
0.50
Shares outstanding
13.02M
No. of employees
16K
Open
$545.00
High
$550.31
Low
$530.38
Mkt. cap
7.14B
Avg. vol.
154.09K
Volume
227.19K
Dividend
0.51%
Quarterly dividend
$0.70
Ex-dividend date
Aug 17, 2026
P/E ratio
26.23
52-wk high
$562.24
52-wk low
$365.20
EPS
$20.91
Beta
0.50
Shares outstanding
13.02M
No. of employees
16K
News stories
From web sources and news partners
About Chemed Corp
CEOKevin J Mcnamara
Employees15.8K
Founded1970
HeadquartersCincinnati, Ohio, United States
SectorHealth care provider
Industry-
Websitechemed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CHE in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CHE in the last 3 months.
Highest
Current $548.64
$675.00 (+23.03%)
Average
$612.00 (+11.55%)
Lowest
$555.00 (+1.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
A.J. Rice
UBS
Buy
Reiterated
$675.00
+23%
10/29/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$625.00
+13.9%
10/29/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$585.00
+6.6%
10/28/2026
Joanna Gajuk
Bank of America Securities
Hold
Reiterated
$555.00
+1.2%
10/28/2026
Brian Tanquilut
Jefferies
Buy
Upgraded
$620.00
+13%
10/27/2026
Last report
Oct 28, 2026
Fiscal period
Q3 2026
$6.75 / $6.44
+4.89%beat
Revenue / Est. (USD)
690.94M / 685.81M
+0.75%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
639.34M
657.51M
673.25M
690.94M
Cost of goods sold
414.17M
441.75M
451.78M
457.98M
Cost of revenue
414.17M
441.75M
451.78M
457.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102.80M
114.32M
115.20M
111.47M
Operating expense
118.91M
131.19M
132.27M
136.54M
Total operating expenses
533.07M
572.94M
584.05M
594.52M
Operating income
106.26M
84.58M
89.20M
96.42M
Other non operating income
3.75M
3.88M
3.70M
2.09M
EBT including unusual items
105.44M
88.84M
91.33M
96.71M
EBT excluding unusual items
111.05M
88.84M
91.33M
96.71M
Income tax expense
28.69M
22.54M
23.63M
25.06M
Effective tax rate
27.21%
25.37%
25.87%
25.91%
Other operating expenses
-225.00K
-8.00K
78.00K
7.67M
Net income
76.75M
66.30M
67.70M
71.65M
Net profit margin
12.00%
10.08%
10.06%
10.37%
Earnings per share
6.42
5.65
6.06
6.75
Interest and investment income
1.56M
890.00K
214.00K
295.00K
Interest expense
-521.00K
-512.00K
-1.79M
-2.10M
Net interest expenses
1.04M
378.00K
-1.58M
-1.80M
Depreciation and amortization charges
13.76M
14.30M
14.27M
14.43M
EBITDA
118.29M
101.45M
106.19M
113.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps